Research coauthored by RTI Health Solutions researchers will be presented at the ESMO 24th World Congress on Gastrointestinal Cancer.
Patient preferences for unresectable hepatocellular carcinoma (HCC) treatments: balancing overall survival and quality of life. Li D, Tan A, Hernandez S, Reilly N, Bussberg CJ, Mansfield C. Poster
